As its traditional market in microbiology matures, bioMerieux is tryiing to branch out into broader areas of infectious diseases. But it is confronting a tough environment with lots of competition and rapid consolidation
By Wendy Diller
Alain Merieux, the owner, CEO, and chairman of bioMerieux SA , likes to say that he is on good...
Join thousands of industry professionals who rely on In Vivo for daily insights
Already a subscriber?
Namrata Saroj, chief business officer of Ocular Therapeutix, is highly respected in the retina community for her contributions to drug development. She talked to In Vivo about her journey in ophthalmology, leadership philosophy and the importance of authenticity in a close-knit specialty.
J&J's EMEA head of digital solutions, Julia Fishman, talks about the hurdles in scaling digital innovation and what’s up next on J&J’s innovation road map. Robot-assisted surgery pioneer Ivo Broeders gives his perspective on the difficulties in clinical adoption.
Emma Hodcroft, co-founder of Pathoplexus and a key Nextstrain contributor, stresses the importance of career flexibility for young scientists. She urges early-stage researchers to embrace curiosity, using her unconventional path as an example of how curiosity can lead to impactful success.
